Z-0961-2025 Class II Ongoing

Recalled by Accriva Diagnostics, Inc. — San Diego, CA

FDA device recall Z-0961-2025 was initiated by Accriva Diagnostics, Inc. on Dec 2, 2024 and is designated Class II. Reason for recall: Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use… The recall status is ongoing. Affected quantity: 25.

Recall details

Product Type
Devices
Report Date
Jan 22, 2025
Initiation Date
Dec 2, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
25

Product description

VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064

Reason for recall

Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent inhibition formula in the notice to manually calculate the percentage of platelet aggregation inhibition for a given patient receiving drug treatment with P2Y12 receptor inhibitor.

Distribution pattern

US Nationwide distribution in the state of VA.

Code information

UDI-DI: 10711234150054. Lot: WL1145. Expiration: 2025-10-18

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0961-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0961-2025. Report a data issue: hello@regdatalab.com.